Sign in
CompletedNo phase

Evaluating Cognitive Outcomes in Down Syndrome

Key facts

Who runs it
Children's Hospital Medical Center, Cincinnati
Where
Cincinnati and Fort Collins, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
202 people enrolled
Started
18 Jun 2018
Ended
17 Jun 2024
Type of study
Observational
Record updated
12 August 2026

Who can take part

Age
6 years to 35 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • 6-35 years old at the time of consent
  • Documented diagnosis of DS
  • Nonverbal mental age of at least 36 months to complete assessment battery (per parent/caregiver/young adult self-report)
  • Willingness to maintain stables dosages of current medication or ongoing treatment for the duration of the study to limit changes while evaluating outcome measures
  • Parent/caregiver/self-report that participant will be able to complete the study, including all visits

Who cannot take part

  • History of blindness, deafness, or serious motor impairment

Where in United States

  • Cincinnati Children's Hospital Medical CenterCincinnati, United States
  • Colorado State UniversityFort Collins, United States

About the trial

What the trial wants to find out

As basic and behavioral science identify new ways to improve cognition and behavior in individuals with Down syndrome (DS), the lack of rigorous outcome measures represents an important problem for interpreting findings. Null findings in clinical trials could result from insensitive outcome measures, rather than ineffectiveness of treatment.

Read full original descriptionShow less

The long-term goal is to improve measurement of outcomes for children and adults with DS. Towards that goal, the investigators propose to test and refine a battery of cognitive measures that can be used in treatment studies focused on school-aged children and adults with Down syndrome. The batteries are designed to assess key domains of the DS phenotype where gaps remain in outcome measures, including attention, executive function, learning and memory, processing speed, and social cognition.

The investigators will examine the psychometric properties of measures (test-retest, validity, sensitivity to change), and to evaluate differences in the psychometric properties of measures as a function of variations in participant age, gender, degree of ID, and the participants' physical health and medical comorbidities. The investigators will evaluate at least 80 children and 50 adults with Down syndrome, per site, at five time points to evaluate key domains with a diverse and novel range of methods. This proposal aims to provide a preliminary evaluation to support the enhancement of clinical outcome measures, which ultimately will increase the accuracy in documenting improvements in the lives of children and young adults with Down syndrome.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluating Cognitive Outcomes in Down Syndrome-2
Record updated
12 August 2026